Kaposi sarcoma associated with rituximab-based cytotoxic therapy


Alkan A., Yasar A., Toprak S.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.26, ss.220-223, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 26 Konu: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1177/1078155219835592
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Sayfa Sayıları: ss.220-223

Özet

Kaposi sarcoma (KS) is a low-grade mesenchymal angioproliferative disease, mostly observed in immune compromised patients. KS is mostly encountered in HIV-positive or organ transplant patients. The drugs causing immunosuppression have also been associated with KS. Here, we present a KS experience associated with rituximab-based therapy.